Stock BIVI BIOVIE INC.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. BioVie Inc.

Equities

BIVI

US09074F2074

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-25 pm EDT 		5-day change 1st Jan Change
0.4889 USD -3.26% Intraday chart for BioVie Inc. +0.10% -61.20%
Mar. 11 BioVie Inc. Announces Pipeline Update and Near-Term Clinical Priorities CI
Mar. 04 Top Midday Decliners MT

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Oppenheimer Adjusts BioVie Price Target to $5 From $12, Maintains Outperform Rating
MT
EF Hutton Adjusts Price Target for BioVie to $8 From $14, Maintains Buy Rating
MT
B. Riley Lowers BioVie's Price Target to $12 from $18 Reflecting More Sharpened Focus of Target Model, Keeps Buy Rating
MT
Cantor Fitzgerald Initiates BioVie at Overweight Rating With $7 Price Target
MT
EF Hutton Adjusts BioVie's Price Target to $14 from $9, Keeps Buy Rating
MT
Oppenheimer Starts BioVie at Outperform With $9 Price Target
MT
B. Riley Lowers BioVie's Price Target to $18 from $27 After Revising Cost Capital Assumptions, Keeps Buy Rating
MT
B. Riley Lowers BioVie's PT to $27 from $50 to Reflect Continued Expansion in Research, Development Spend, Stretched Out Commercialization Timelines; Keeps Buy Rating
MT
BIOVIE : B. Riley Raises BioVie's PT to $50 from $47 On Liver, Neurodegenerative, and Oncology Pipeline, Keeps Buy Rating
MT
DJ Industrial : Stocks Fall Ahead of Fed Rate Decision
MT
Midday Report: Wall Street Falls Ahead of Fed Rate Decision
MT
BIOVIE : B. Riley Starts BioVie at Buy With $47 Price Target
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. BIVI Stock
  4. News BioVie Inc.
  5. Analyst Reco.